55 related articles for article (PubMed ID: 6454962)
1. [Cardiovascular diseases after kidney transplantation: an analysis of predisposing factors].
Heule H; Keusch G; Uhlschmid G; Largiadèr F; Binswanger U
Schweiz Med Wochenschr; 1981 May; 111(20):709-16. PubMed ID: 6454962
[TBL] [Abstract][Full Text] [Related]
2. Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study.
Brunkhorst R; Lufft V; Dannenberg B; Kliem V; Tusch G; Pichlmayr R
Transplantation; 2003 Jul; 76(1):115-9. PubMed ID: 12865796
[TBL] [Abstract][Full Text] [Related]
3. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
[TBL] [Abstract][Full Text] [Related]
4. [Frequency of cardiovascular risk factors in renal transplant patients (author's transl)].
Zazgornik J; Balcke P; Schmidt P; Kopsa H
Wien Klin Wochenschr; 1978 Jun; 90(13):466-8. PubMed ID: 351973
[TBL] [Abstract][Full Text] [Related]
5. Incidence of cardiovascular risk factors and complications before and after kidney transplantation.
Fazelzadeh A; Mehdizadeh A; Ostovan MA; Raiss-Jalali GA
Transplant Proc; 2006 Mar; 38(2):506-8. PubMed ID: 16549161
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk factors in non-diabetic hemodialysis patients: a comparative study.
Tzanatos HA; Tseke PP; Pipili C; Retsa K; Skoutelis G; Grapsa E
Ren Fail; 2009; 31(2):91-7. PubMed ID: 19212904
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk estimates and risk factors in renal transplant recipients.
Krämer BK; Böger C; Krüger B; Marienhagen J; Pietrzyk M; Obed A; Paczek L; Mack M; Banas B
Transplant Proc; 2005 May; 37(4):1868-70. PubMed ID: 15919488
[TBL] [Abstract][Full Text] [Related]
8. Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia.
Lin KC; Tsao HM; Chen CH; Chou P
J Rheumatol; 2004 Jun; 31(6):1152-8. PubMed ID: 15170929
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for cardiovascular disease during the first 2 years after renal transplantation.
Laurés AS; Gómez E; Baltar J; Alvarez-Grande J
Transplant Proc; 2005 Nov; 37(9):3778-81. PubMed ID: 16386536
[TBL] [Abstract][Full Text] [Related]
10. Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone.
Biesenbach G; Königsrainer A; Gross C; Margreiter R
Transpl Int; 2005 Sep; 18(9):1054-60. PubMed ID: 16101726
[TBL] [Abstract][Full Text] [Related]
11. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
[TBL] [Abstract][Full Text] [Related]
12. Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients?
Fleischmann EH; Bower JD; Salahudeen AK
Clin Nephrol; 2001 Sep; 56(3):221-30. PubMed ID: 11597037
[TBL] [Abstract][Full Text] [Related]
13. Kidney transplantation candidates and cardiovascular risk factors.
Noshad H; Ardalan MR; Mortazavi M; Tayebi H; Safa J; Nezami N
Transplant Proc; 2007 May; 39(4):871-4. PubMed ID: 17524836
[TBL] [Abstract][Full Text] [Related]
14. Is there disparity between risk and incidence of cardiovascular disease after liver transplant?
Neal DA; Tom BD; Luan J; Wareham NJ; Gimson AE; Delriviere LD; Byrne CD; Alexander GJ
Transplantation; 2004 Jan; 77(1):93-9. PubMed ID: 14724441
[TBL] [Abstract][Full Text] [Related]
15. Uric acid: role in cardiovascular disease and effects of losartan.
Alderman M; Aiyer KJ
Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for cardiovascular disease after renal transplantation.
Kasiske BL
Miner Electrolyte Metab; 1993; 19(3):186-95. PubMed ID: 8232106
[TBL] [Abstract][Full Text] [Related]
17. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M
Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511
[TBL] [Abstract][Full Text] [Related]
19. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
